Lawsuit Notice: NASDAQ: CGNT Investors who lost over $200,000 with shares of Cognyte Software Ltd. should contact the Shareholders Foundation.


SAN DIEGO, April 10, 2023 (GLOBE NEWSWIRE) -- The Shareholders Foundation, Inc. announces that a deadline is coming up in the lawsuit that was filed for certain investors in shares of Cognyte Software Ltd. (NASDAQ: CGNT).

Investors who purchased shares in excess of $200,000 of Cognyte Software Ltd. (NASDAQ: CGNT) have certain options and there are short and strict deadlines running. New Deadline: May 1, 2023. Those NASDAQ: CGNT investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

On March 1, 2023, a lawsuit was filed in the U.S against Cognyte Software LTD, its Chief Executive Officer, and its Chief Financial Officer. The plaintiff alleges that the Defendants misled investors and/or failed to disclose that Cognyte Software created, distributed, and provided reconnaissance tools and services that violated community standards and terms of service of communication network sources and technologies, such as Facebook, exposing the Company to significant financial and reputational risk.

Those who purchased Cognyte Software Ltd. (NASDAQ: CGNT) shares should contact the Shareholders Foundation, Inc.

CONTACT:
Shareholders Foundation, Inc. 
Michael Daniels 
+1 (858) 779-1554 
mail@shareholdersfoundation.com 
3111 Camino Del Rio North 
Suite 423 
San Diego, CA 92108

The Shareholders Foundation, Inc. is a professional portfolio legal monitoring and a settlement claim filing service, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. The Shareholders Foundation, Inc. is not a law firm. Any referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is only provided as a public service. It is not intended as legal advice and should not be relied upon.